302 related articles for article (PubMed ID: 14646033)
1. Anti-cardiolipin and anti-beta2-glycoprotein I (beta2GP-I) antibody assays as screening for anti-phospholipid syndrome.
Marai I; Gilburd B; Blank M; Shoenfeld Y
Hum Antibodies; 2003; 12(3):57-62. PubMed ID: 14646033
[TBL] [Abstract][Full Text] [Related]
2. Comparison of different kits in the detection of autoantibodies to cardiolipin and beta2glycoprotein 1.
Audrain MA; Colonna F; Morio F; Hamidou MA; Muller JY
Rheumatology (Oxford); 2004 Feb; 43(2):181-5. PubMed ID: 14585922
[TBL] [Abstract][Full Text] [Related]
3. Characterization of IgG monoclonal anti-cardiolipin/anti-beta2GP1 antibodies from two patients with antiphospholipid syndrome reveals three species of antibodies.
Zhu M; Olee T; Le DT; Roubey RA; Hahn BH; Woods VL; Chen PP
Br J Haematol; 1999 Apr; 105(1):102-9. PubMed ID: 10233371
[TBL] [Abstract][Full Text] [Related]
4. [Antibodies to beta2-glycoprotein I and antibodies to cardiolipin in antiphospholipid syndrome: analysis of sensitivity and specificity].
Aleksandrova EN; Novikov AA; Reshetniak TM; Kliukvina HG; Reshetniak DV; Nasonov EL
Klin Med (Mosk); 2003; 81(9):25-31. PubMed ID: 14598587
[TBL] [Abstract][Full Text] [Related]
5. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM
J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of antibodies to beta2-glycoprotein 1 from patients with systemic lupus erythematosus.
Cabral AR; Cabiedes J; Alarcón-Segovia D
Lupus; 2004; 13(3):182-7. PubMed ID: 15119547
[TBL] [Abstract][Full Text] [Related]
7. Antibodies to phospholipid-free beta 2-glycoprotein-I in patients with primary antiphospholipid syndrome.
Cabral AR; Cabiedes J; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1894-8. PubMed ID: 8991988
[TBL] [Abstract][Full Text] [Related]
8. Reactivity to beta 2 glycoprotein I clearly differentiates anticardiolipin antibodies from antiphospholipid syndrome and syphilis.
Forastiero RR; Martinuzzo ME; Kordich LC; Carreras LO
Thromb Haemost; 1996 May; 75(5):717-20. PubMed ID: 8725711
[TBL] [Abstract][Full Text] [Related]
9. A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies.
Ichikawa K; Tsutsumi A; Atsumi T; Matsuura E; Kobayashi S; Hughes GR; Khamashta MA; Koike T
Arthritis Rheum; 1999 Nov; 42(11):2461-70. PubMed ID: 10555042
[TBL] [Abstract][Full Text] [Related]
10. IgG anti-beta(2) glycoprotein I antibodies in Malaysian patients with antiphospholipid syndrome and systemic lupus erythematosus: prevalence and clinical correlations.
Ong SG; Cheng HM; Soon SC; Goh E; Chow SK; Yeap SS
Clin Rheumatol; 2002 Sep; 21(5):382-5. PubMed ID: 12223986
[TBL] [Abstract][Full Text] [Related]
11. Anti-beta2-glycoprotein I autoantibodies, in vitro thrombin generation, and the antiphospholipid syndrome.
Hanly JG; Smith SA
J Rheumatol; 2000 Sep; 27(9):2152-9. PubMed ID: 10990227
[TBL] [Abstract][Full Text] [Related]
12. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
Lopez LR; Simpson DF; Hurley BL; Matsuura E
Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
[TBL] [Abstract][Full Text] [Related]
13. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome.
Romero FI; Atsumi T; Tinahones FJ; Gómez-Zumaquero JM; Amengual O; Khamashta MA; Hughes GR
Arthritis Rheum; 1999 Dec; 42(12):2606-11. PubMed ID: 10616007
[TBL] [Abstract][Full Text] [Related]
15. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
Arnoux D; Boutière B; Sanmarco M
Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
[TBL] [Abstract][Full Text] [Related]
16. Reactivity profiles of autoantibodies to different phospholipids and the phospholipid-binding protein beta2-glycoprotein I in patients with clinical symptoms related to thromboembolic and/or vasculopathic events with or without connective tissue diseases.
Jaekel HP; Schmid D; Müller EW; Ziutelis V; Trabandt A; Grobe N; Kaskel-Paul S; Höh H; Bauer B; Sudik R; Baldauf A; Werle E
Clin Lab; 2003; 49(7-8):345-55. PubMed ID: 12908734
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
[TBL] [Abstract][Full Text] [Related]
18. Comparison between the standard anticardiolipin antibody test and a new phospholipid test in patients with connective tissue diseases.
Merkel PA; Chang Y; Pierangeli SS; Harris EN; Polisson RP
J Rheumatol; 1999 Mar; 26(3):591-6. PubMed ID: 10090168
[TBL] [Abstract][Full Text] [Related]
19. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
Bertolaccini ML; Hughes GR; Khamashta MA
Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
[TBL] [Abstract][Full Text] [Related]
20. Anti-beta2-glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome.
von Scheven E; Glidden DV; Elder ME
Arthritis Rheum; 2002 Aug; 47(4):414-20. PubMed ID: 12209489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]